Combined with intravenous dopamine and furosemide in treatment of refractory congestive heart failure evaluation.docVIP

Combined with intravenous dopamine and furosemide in treatment of refractory congestive heart failure evaluation.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
 PAGE \* MERGEFORMAT 2 Combined with intravenous dopamine and furosemide in treatment of refractory congestive heart failure evaluation [Keywords:] dopamine; furosemide; heart failure, refractory [Keywords:] dopamine; furosemide; heart failure, refractory 0 Introduction Refractory heart failure (refractory heart failure, RHF) is the heart of the severe phase of the conventional cardiac, diuretic, vasodilator drugs such as poor response to treatment, symptoms persist and even increase sexual, clinical high mortality . 200301/200511 our hospital of 90 patients with refractory heart failure combined with intravenous application of dopamine and furosemide treatment, and achieved satisfactory results. An object and method 1.1 Object stay I Section 90 cases of heart function classification (NYHA) [1] for grade Ⅲ ~ Ⅳ RHF patients were randomly divided into two groups, treatment group, 45 (male 27, female 18) patients, aged 27 to 87 years old, coronary atherosclerotic heart disease in 12 cases, hypertensive heart disease in 10 cases, 9 cases of pulmonary heart disease, rheumatic heart disease in 7 cases, 5 cases of dilated cardiomyopathy, congenital heart disease in 2 cases; the control group 45 (male 24, female 21) patients, aged 36 to 89 years old, coronary atherosclerotic heart disease in 18 cases, 12 cases of hypertensive heart disease, pulmonary heart disease in 7 cases, 5 cases of rheumatic heart disease , dilated cardiomyopathy in 3 patients. the two groups of gender, age, duration of treatment prior to cardiac function classification and left ventricular ejection fraction (LVEF) were no statistically significant difference (P

您可能关注的文档

文档评论(0)

hhuiws1482 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5024214302000003

1亿VIP精品文档

相关文档